Wuhan YZY Biopharma Co., Ltd. (HKG:2496)

Wuhan YZY Biopharma Statistics

Total Valuation

HKG:2496 has a market cap or net worth of HKD 891.71 million. The enterprise value is 922.52 million.

Market Cap	891.71M
Enterprise Value	922.52M

Important Dates

The last earnings date was Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2496 has 193.85 million shares outstanding.

Current Share Class	179.48M
Shares Outstanding	193.85M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	19.52%
Owned by Institutions (%)	8.61%
Float	22.73M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.99
PB Ratio	-15.11
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-9.78
EV / Sales	12.40
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-36.90

Financial Position

The company has a current ratio of 0.66

Current Ratio	0.66
Quick Ratio	0.57
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-5.69
Interest Coverage	-16.27

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-22.74%
Return on Invested Capital (ROIC)	-43.29%
Return on Capital Employed (ROCE)	315.57%
Weighted Average Cost of Capital (WACC)	6.40%
Revenue Per Employee	701,889
Profits Per Employee	-889,534
Employee Count	106
Asset Turnover	0.30
Inventory Turnover	14.88

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.13% in the last 52 weeks. The beta is 0.49, so HKG:2496's price volatility has been lower than the market average.

Beta (5Y)	0.49
52-Week Price Change	-2.13%
50-Day Moving Average	5.28
200-Day Moving Average	6.35
Relative Strength Index (RSI)	32.27
Average Volume (20 Days)	1,440

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2496 had revenue of HKD 74.40 million and -94.29 million in losses. Loss per share was -0.49.

Revenue	74.40M
Gross Profit	11.95M
Operating Income	-89.65M
Pretax Income	-94.29M
Net Income	-94.29M
EBITDA	-85.42M
EBIT	-89.65M
Loss Per Share	-0.49

Balance Sheet

The company has 111.35 million in cash and 142.17 million in debt, with a net cash position of -30.82 million or -0.16 per share.

Cash & Cash Equivalents	111.35M
Total Debt	142.17M
Net Cash	-30.82M
Net Cash Per Share	-0.16
Equity (Book Value)	-59.01M
Book Value Per Share	-0.30
Working Capital	-76.38M

Cash Flow

In the last 12 months, operating cash flow was -24.01 million and capital expenditures -989,288, giving a free cash flow of -25.00 million.

Operating Cash Flow	-24.01M
Capital Expenditures	-989,288
Depreciation & Amortization	4.38M
Net Borrowing	310,926
Free Cash Flow	-25.00M
FCF Per Share	-0.13

Margins

Gross margin is 16.06%, with operating and profit margins of -120.50% and -126.73%.

Gross Margin	16.06%
Operating Margin	-120.50%
Pretax Margin	-126.73%
Profit Margin	-126.73%
EBITDA Margin	-114.81%
EBIT Margin	-120.50%
FCF Margin	n/a

Dividends & Yields

HKG:2496 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-10.57%
FCF Yield	-2.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2496 has an Altman Z-Score of -3.56 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.56
Piotroski F-Score	2